Therefore operators should only be admissible on condition that , within a particular period of time before lodging an application for aid, they were not involved in the operation, management or ownership of fishing vessels included in the Union IUU vessel list as set out in Article 40(3) of Council Regulation (EC) No 1005/2008 of 29 September 2008 establishing a Community system to prevent, deter and eliminate illegal, unreported and unregulated fishing, amending Regulation (EEC) No 2847/93, (EC) No 1936/2001 and (EC) No 601/2004 and repealing Regulations (EC) No 1093/94 and (EC) No 1447/1999, and they were not involved in the operation ...[+++], management or ownership of fishing vessels flagged to countries identified as non–cooperating third countries as referred to in Article 33 of Regulation (EC) No 1005/2008.

4. Emphasises the importance of developing the legal concept of shared ownership - in order to ensure full recognition of women's rights in the agricultural sector, appropriate protection in the field of social security and recognition of women's work - and the need to amend the European Agricultural Fund for Rural Development (EAFRD) Regulation, so as to make it possible, as is the case under the European Social Fund (ESF), to take positive action for women in the future 2014-2020 programming period, bearing in mind that this was feasible in earlier periods but cannot be done in the current one and that such measures will have very bene ...[+++]ficial effects on female employment in rural areas;

4. Emphasises the importance of developing the legal concept of shared ownership - in order to ensure full recognition of women’s rights in the agricultural sector, appropriate protection in the field of social security and recognition of women’s work - and the need to amend the European Agricultural Fund for Rural Development (EAFRD) Regulation, so as to make it possible, as is the case under the European Social Fund (ESF), to take positive action for women in the future 2014-2020 programming period, bearing in mind that this was feasible in earlier periods but cannot be done in the current one and that such measures will have very bene ...[+++]ficial effects on female employment in rural areas;

85. Emphasises the importance of developing the legal construct of shared ownership with the aim of ensuring that women’s rights in the agricultural sector are fully recognised, that they receive appropriate social security protection and that their work is recognised; stresses, moreover, the need for the European Agricultural Fund for Rural Development (EAFRD) Regulation to be amended to enable, as with the European Social Fund (ESF), proactive measures to be taken in support of women in the 2014-2020 programming period, which was feasible in previous periods but not in the current one, and which will have very beneficial effects on fe ...[+++]male employment in rural areas;

74. Emphasises the importance of developing the legal construct of shared ownership with the aim of ensuring that women's rights in the agricultural sector are fully recognised, that they receive appropriate social security protection and that their work is recognised; stresses, moreover, the need for the European Agricultural Fund for Rural Development (EAFRD) Regulation to be amended to enable, as with the European Social Fund (ESF), proactive measures to be taken in support of women in the 2014-2020 programming period, which was feasible in previous periods but not in the current one, and which will have very beneficial effects on fe ...[+++]male employment in rural areas;

11. Without prejudice to the law on the protection of industrial and commercial property, medicinal products for human use which have been authorised in accordance with the provisions of this Regulation shall benefit from an eight-year period of data protection and a ten-year period of marketing protection, in which connection the latter period shall be extended to a maximum of 11 years if, during the first eight years of those ten years, the marketing authorisation holder obtains an authorisation for one or more new therapeutic indications which, during the scientific evaluation prior to their authorisation, are held to bring a signific ...[+++]ant clinical benefit in comparison with existing therapies.